ID: ALA2017023

Max Phase: Preclinical

Molecular Formula: C13H20N6O6S

Molecular Weight: 388.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCNc1ncnc2c1ncn2[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C13H20N6O6S/c1-2-3-15-11-8-12(17-5-16-11)19(6-18-8)13-10(21)9(20)7(25-13)4-24-26(14,22)23/h5-7,9-10,13,20-21H,2-4H2,1H3,(H2,14,22,23)(H,15,16,17)/t7-,9-,10-,13-/m1/s1

Standard InChI Key:  GXWGVKAJLXAXLH-QYVSTXNMSA-N

Associated Targets(Human)

SUMO-activating enzyme 861 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ubiquitin-like modifier-activating enzyme 5 22 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 388.41Molecular Weight (Monoisotopic): 388.1165AlogP: -1.51#Rotatable Bonds: 7
Polar Surface Area: 174.71Molecular Species: NEUTRALHBA: 11HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.30CX Basic pKa: 3.76CX LogP: -1.43CX LogD: -1.43
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.44Np Likeness Score: 0.32

References

1. Lukkarila JL, da Silva SR, Ali M, Shahani VM, Xu GW, Berman J, Roughton A, Dhe-Paganon S, Schimmer AD, Gunning PT..  (2011)  Identification of NAE Inhibitors Exhibiting Potent Activity in Leukemia Cells: Exploring the Structural Determinants of NAE Specificity.,  (8): [PMID:24900352] [10.1021/ml2000615]

Source